Cargando…

Prominent Mutation of Intron 22 Inversion in Sporadic Hemophilia: Is It Worth the Antenatal Screening?

BACKGROUND: Adequate replacement for patients with hemophilia is costly, especially in countries with limited resources. OBJECTIVE: Factor VIII gene mutations among Thai patients with hemophilia A were analyzed for the most common mutation. The cost-effectiveness of finding one female without family...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sasanakul, Werasak, Chuansumrit, Ampaiwan, Sirachainan, Nongnuch, Kadegasem, Praguywan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126152/ https://www.ncbi.nlm.nih.gov/pubmed/35615343 http://dx.doi.org/10.2147/TACG.S363132

Ejemplares similares

Three-Decade Successive Establishment of Care for Women/Girls from Families with Haemophilia
por: Chuansumrit, Ampaiwan, et al.
Publicado: (2022)

Coagulant activity of recombinant human factor VII produced by lentiviral human F7 gene transfer in immortalized hepatocyte-like cell line
por: Pongjantarasatian, Sarai, et al.
Publicado: (2019)

Multicenter Study of Diagnostic Tool for Patients with Hemophilia: From Bedside to Comprehensive Investigations
por: Chuansumrit, Ampaiwan, et al.
Publicado: (2023)

The Association Between HLA Class II Alleles and the Occurrence of Factor VIII Inhibitor in Thai Patients with Hemophilia A
por: Nathalang, Oytip, et al.
Publicado: (2012)

High Prevalence of Antiphospholipid Antibodies in Children with Non-Transfusion Dependent Thalassemia and Possible Correlations with Microparticles
por: Chinsuwan, Jitlada, et al.
Publicado: (2020)

PROC Promoter Single Nucleotide Polymorphisms Associated With Low Protein C Activity But Not Increased Risk of Thromboembolism in Pediatric Population
por: Udomkittivorakul, Natsumon, et al.
Publicado: (2020)

Critical appraisal of the role of recombinant activated factor VII in the treatment of hemophilia patients with inhibitors
por: Chuansumrit, Ampaiwan, et al.
Publicado: (2010)

No differences in hemostatic and endothelial activations between haploidentical and matched-donor hematopoietic stem cell transplantation in thalassemia disease
por: Lertthammakiat, Surapong, et al.
Publicado: (2020)

Frequency of Intron 22 Inversion in Severe Hemophilia A Patients
por: Ashfaq, Javeria, et al.
Publicado: (2022)

Under-recognized Hypoparathyroidism in Thalassemia
por: Tangngam, Hataitip, et al.
Publicado: (2018)

Mutations of TFPI-binding exosites on factor VII cause bleeding phenotypes in factor VII deficiency
por: Seanoon, Karnsasin, et al.
Publicado: (2022)

Screening for ELANE, HAX1 and GFI1 gene mutations in children with neutropenia and clinical characterization of two novel mutations in ELANE gene
por: Komvilaisak, Patcharee, et al.
Publicado: (2023)

Factor VIII Intron 22 Inversion in Severe Hemophilia A Patients in Palestine
por: Mahmoud Abu Arra, Caesar, et al.
Publicado: (2020)

Identification of the Intron 22 and Intron 1 Inversions of the Factor VIII Gene in Iraqi Kurdish Patients With Hemophilia A
por: Abdulqader, Aveen M. Raouf, et al.
Publicado: (2020)

Synthesis of FVIII in Hemophilia-A patients with the intron-22-inversion may modulate immunogenicity
por: Pandey, Gouri Shankar, et al.
Publicado: (2013)

Novel Severe Hemophilia A Mouse Model with Factor VIII Intron 22 Inversion
por: Han, Jeong Pil, et al.
Publicado: (2021)

In situ genetic correction of F8 intron 22 inversion in hemophilia A patient-specific iPSCs
por: Wu, Yong, et al.
Publicado: (2016)

Large Intron Inversions in Romanian Patients with Hemophilia A—First Report
por: Brinza, Melen, et al.
Publicado: (2023)

Factor VIII inhibitor development in Egyptian hemophilia patients: does intron 22 inversion mutation play a role?
por: Sherief, Laila M., et al.
Publicado: (2020)

Hemophilia A subjects with an intron-22 gene inversion mutation show CD4(+) T-effector responses to multiple epitopes in FVIII
por: Gunasekera, Devi, et al.
Publicado: (2023)

Practices and challenges for hemophilia management under resource constraints in Thailand
por: Moonla, Chatphatai, et al.
Publicado: (2023)

Activation of a cryptic splice site in a potentially lethal coagulation defect accounts for a functional protein variant
por: Cavallari, Nicola, et al.
Publicado: (2012)

Nonacog beta pegol (N9‐GP) in hemophilia B: First report on safety and efficacy in previously untreated and minimally treated patients
por: Chan, Anthony K., et al.
Publicado: (2020)

Prophylactic emicizumab for hemophilia A in the Asia‐Pacific region: A randomized study (HAVEN 5)
por: Yang, Renchi, et al.
Publicado: (2022)

Mutations in Intron 1 and Intron 22 Inversion Negative Haemophilia A Patients from Western India
por: Nair, Preethi S., et al.
Publicado: (2014)

Screening of Intron 1 Inversion of the Factor VIII Gene in 130 Patients with Severe Hemophilia A from a Pakistani Cohort
por: Sattar, Azhar, et al.
Publicado: (2017)

Desmopressin in moderate hemophilia A patients: a treatment worth considering
por: Loomans, Janneke I., et al.
Publicado: (2018)

Pediatric standardized bleeding assessment tool for screening bleeding disorder in school-age children
por: Laoaroon, Napat, et al.
Publicado: (2022)

Vascular Leakage in Dengue Hemorrhagic Fever Is Associated with Dengue Infected Monocytes, Monocyte Activation/Exhaustion, and Cytokines Production
por: Chunhakan, Sirichan, et al.
Publicado: (2015)

Prominent and conspicuous astrocyte atrophy in human sporadic and familial Alzheimer’s disease
por: Rodríguez, J. J., et al.
Publicado: (2023)

Correction of F8 intron 1 inversion in hemophilia A patient-specific iPSCs by CRISPR/Cas9 mediated gene editing
por: Hu, Zhiqing, et al.
Publicado: (2023)

Acute Effects of Blood Transfusion on Insulin Sensitivity and Pancreatic β-Cell Function in Children with β-Thalassemia/Hemoglobin E Disease
por: Wankanit, Somboon, et al.
Publicado: (2018)

Arrangements for the Meeting at Fort Worth, April 22, 1890
por: Adams, W. A.
Publicado: (1890)

Arrangements for the Meeting at Fort Worth, April 22, 1890
por: Burts, W. P.
Publicado: (1890)

Point: Antenatal corticosteroid treatment in the late preterm period—Are the benefits worth the potential risks?
por: Kajantie, Eero
Publicado: (2022)

Intracardiac thrombus in a patient with catastrophic antiphospholipid syndrome: an autopsy case report and review of the literature
por: Waisayarat, Jariya, et al.
Publicado: (2019)

Eighteen Years of Molecular Genotyping the Hemophilia Inversion Hotspot: From Southern Blot to Inverse Shifting-PCR
por: Rossetti, Liliana C., et al.
Publicado: (2011)

Assessment of the stated policies of prominent food companies related to obesity and non-communicable disease (NCD) prevention in Thailand
por: Cetthakrikul, Nisachol, et al.
Publicado: (2019)

Identification of Alpha Thalassemia, RNF213 p.R4810K and PROC p.R189W among Children with Moyamoya Disease/Syndrome
por: Thampratankul, Lunliya, et al.
Publicado: (2022)

The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis
por: Gang, Qiang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9reafiasp599m0vj2e5n43n8s6